Last Updated on July 22, 2018 by Joseph Gut – thasso July 22, 2018 – The American Food and Drug Administration (FDA) just approved Ivosidenib (Tibsovo) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who …

Ivosidenib (Tibsovo) for AML-patients with IDH1-mutations Read more »

Last Updated on July 7, 2018 by Joseph Gut – thasso July 07, 2018 – A very recent paper by Loftfield E. et al., published online in JAMA Intern. Med. on July 02, looked at the association of coffee drinking …

Coffee Drinking, Genetic Variation, and Mortality Read more »